Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,307
Total Claims
$652K
Drug Cost
575
Beneficiaries
$1,133
Cost/Patient
Risk Score Breakdown 30/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+32%
Opioid rate vs peers
3.4% vs 2.6% avg
+6%
Cost per patient vs peers
$1,133 vs $1,068 avg
+66%
Brand preference vs peers
14.9% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.4%
Opioid Rate
351
Opioid Claims
$17K
Opioid Cost
36.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,527 claims · $479K
Generic: 8,726 claims · $171K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 242 | $104K |
| Dulaglutide | 34 | $35K |
| Insulin Glargine,hum.Rec.Anlog | 56 | $26K |
| Semaglutide | 22 | $21K |
| Tirzepatide | 13 | $21K |
| Insulin Aspart | 27 | $18K |
| Budesonide/Formoterol Fumarate | 28 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 14 | $14K |
| Empagliflozin | 34 | $12K |
| Fentanyl | 97 | $12K |
| Insulin Detemir | 26 | $11K |
| Ipratropium/Albuterol Sulfate | 22 | $11K |
| Insulin Aspart | 15 | $11K |
| Insulin Lispro | 18 | $11K |
| Sitagliptin Phosphate | 35 | $10K |
Prescribing Profile
Patient Profile
74
Avg Age
51%
Female
1.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About